sign in sign up
<<
Home , Diphenylpyraline

THE NATIONAL DRUG POLICY AND AUTHORITY ACT.

Statutory Instrument 206—1.

The National Drug Policy and Authority Regulations.

Arrangement of Regulations.

Regulation

Preliminary.

1. Citation.

Classified drugs.

2. Possession of classified drugs, etc. for industrial use, storage of the drugs and avoidance of risks. 3. Sale of classified drug, etc. by licensed sellers. 4. Sale of classified drugs for mining, agricultural or horticultural purposes. 5. Labelling of containers. 6. Indications of character of classified drug and restricted drug. 7. Directions as to use. 8. Containers for classified drug or restricted drug. 9. Special provisions with respect to hospitals. 10. Marking of packages or bottles. 11. Specified provisions with respect to gifts by representatives. 12. Special provisions with respect to midwives.

Manufacture and sale of narcotics, etc.

13. Possession of narcotics and psychotropic substances. 14. No person to manufacture certain drugs without licence or authority. 15. Licence to supply narcotics, etc. 16. Persons authorised to possess and supply narcotics and psychotropic substances without licence. 17. Delivery of drugs to messengers. 18. Preservation of records.

Import and export of narcotic and psychtropic drugs.

19. Export of drugs. 20. Import of drugs. 21. Restriction of sales by licensed sellers. 22. Metric system and imperial system. 23. Offences and penalties.

Schedules

First Schedule Indication of character of article prescribed for the purposes of section 25 of the Act.

Second Schedule Statement of particulars permitted in certain cases as to proportion of poison.

Third Schedule Limitations on forms of sale and buyers of restricted drugs.

Fourth Schedule Substances dealing in which are subject to control under international conventions.

Fifth Schedule List of psychotropic substances included in the Schedules annexed to the Convention of 21st February, 1971.

Sixth Schedule Import authorisation and certificate of official approval of import.

Seventh Schedule Duplicate of import licence.

Eighth Schedule Export authorisation.

THE NATIONAL DRUG POLICY AND AUTHORITY ACT.

Statutory Instrument 206—1.

The National Drug Policy and Authority Regulations. (Under section 64 of the Act.)

Preliminary.

1. Citation.

These Regulations may be cited as the National Drug Policy and Authority Regulations.

Classified drugs.

2. Possession of classified drugs, etc. for industrial use, storage of the drugs and avoidance of risks.

(1) Any person who imports a classified drug or restricted drug for industrial purposes in accordance with section 46 of the Act may lawfully possess that classified drug or restricted drug in the quantity authorised under the permit.

(2) Any person who imports a classified drug or restricted drug for industrial purposes in accordance with these Regulations may sell the classified or restricted drugs so imported to the person named in the application as the purchaser, and the purchaser may, notwithstanding section 27 of the Act, lawfully possess the classified drug or restricted drug.

(3) The importer and the user shall provide adequate safe storage and protective clothing, and avoid all risks arising out of misuse.

3. Sale of classified drug, etc. by licensed sellers.

(1) A licensed seller holding a valid licence issued under section 15 of the Act shall not sell any classified drug or restricted drug, other than ammonia, hydrochloric acid, nitric acid, potassium quadroxalate and sulphuric acid, except in a closed container as closed by the manufacturer or other person from whom the restricted drug was obtained.

(2) Any person who fails to comply with subregulation (1) of this regulation commits an offence.

4. Sale of classified drugs for mining, agricultural or horticultural purposes.

(1) No person shall be entitled by virtue of being licensed to deal in a classified drug or restricted drug for mining, agricultural or horticultural purposes to sell or offer for sale any classified drug or restricted drug unless he or she is authorised to do so by his or her licence.

(2) A person licensed to deal in a classified drug or a restricted drug for mining, agricultural and horticultural purposes may not sell— (a) any classified drug or restricted drug, other than ammonia, hydrochloric acid, potassium quadroxalate and sulphuric acid, except in a closed container as closed by the manufacturer or other person from whom the classified drug or restricted drug was obtained; (b) any classified drug or restricted drug unless— (i) the purchaser of the drug is a person engaged in the trade, business or profession of mining, agriculture or horticulture and requires the classified drug or restricted drug for the purposes of his or her trade, business or profession; (ii) the sale is made by one of the persons named in the application for the licence to sell the classified drug or restricted drug; (iii) the classified drug or restricted drug, if it is one of the substances referred to in the First Schedule to these Regulations is, in addition to any other requirements of the Act and these Regulations, labelled in the manner described in that Schedule; and (iv) the requirements of section 24 of the Act are complied with.

(3) Any person who fails to comply with any provision of subregulation (2) of this regulation commits an offence.

5. Labelling of containers.

(1) Every container of a classified drug or restricted drug shall be

labelled clearly and distinctly in the English language in the following manner— (a) the name of the classified drug or restricted drug shall be the term by which it is described in the First and Second Schedules to the Act; except that— (i) where that term describes a group of classified drugs or restricted drugs and not the classified drug or restricted drug specifically, the name of the classified drug or restricted drug shall be— (A) if the classified drug or restricted drug is the subject of a monograph in either the British Pharmacopoeia or the British Pharmaceutical Codex or the British Veterinary Codex or the United States Pharmacopoeia, or the International Pharmacopoeia, one or other of the names, synonyms or abbreviated names set out at the head of the monograph; and (B) in any other case, the accepted scientific name descriptive of the true nature and origin of the classified drug or restricted drug, and in those cases the appropriate name of the classified drug or restricted drug shall be written in English; (ii) in the case of a preparation or any dilution or admixture of the preparation in the British Pharmacopoeia or the British Pharmaceutical Codex or the British Veterinary Codex or the United States Pharmacopoeia or the International Pharmacopoeia, or any surgical dressing for which a standard is described in the British Pharmaceutical Codex, it shall be sufficient to state the name, synonym or abbreviated name used to describe the preparation or surgical dressing in the British Pharmacopoeia or the British Pharmaceutical Codex or the British Veterinary Codex or the United States Pharmacopoeia or the International Pharmacopoeia with the addition of the letters B.P. or B.P.C. or B. Vet. C. or U.S.P. or I.P. as the case may be; (b) the particulars as to the proportion which a classified drug or restricted drug contained in a preparation bears to the total ingredients shall be expressed as the percentage which the classified drug or restricted drug bears to the total ingredients; except that— (i) in the case of a preparation containing a classified drug or restricted drug specified in column one of the Second Schedule to these Regulations, it shall be sufficient to state

on the label the particulars specified in column two of that Schedule against the description of the classified drug or restricted drug; (ii) in the case of a preparation or surgical dressing which is named in accordance with paragraph (a)(ii) of this subregulation, it shall not be necessary to state on the label the proportion of the classified drug or restricted drug contained in the preparation, and in the case of any dilution or admixture of such a preparation, it shall be sufficient to state the proportion which the preparation bears to the total ingredients of the dilution or admixture; (iii) where the classified drug or restricted drug is in tablets, pills, cachets, capsules, lozenges or similar articles, it shall be sufficient to state on its container, the number of the articles, and the amount of the classified drug or restricted drug or the amount of preparation contained in each tablet, pill, cachet, capsule, lozenge or other similar article; (iv) the words “classified drug or restricted drug” or the alternative indication of character specified in regulation 6 of these Regulations, as the case may be, shall— (A) in the case of a poison not specified in the Second Schedule to the Act, either be printed in red letters on a contrasting background or in letters of some other colour set against a red background; (B) in all cases, be easily legible and either on a separate label or surrounded by a line within which there must be no other words.

(2) Where any proportion is stated as a percentage, the statement shall indicate whether the percentage is calculated on the basis of weight in weight or in volume or volume in volume.

(3) Directions for the use of any classified drug or restricted drug shall be given in the English language, in addition to any other language.

(4) Where a classified drug or restricted drug is contained in a cachet or other similar article, only the box or receptacle containing the cachets or other articles need be labelled.

(5) Where the container of a classified drug or restricted drug or the container of a cachet or other similar article is labelled in accordance with this regulation, any other cover or wrapper to that container used only for the

purpose of delivery or transport need not be similarly labelled if it complies with the Eighth Schedule to the Act.

(6) Every person who sells any classified drug or restricted drug not labelled in accordance with this regulation commits an offence.

6. Indications of character of classified drug and restricted drug.

(1) Any classified drug or restricted drug specified in the First, Second or Third Schedule to the Act shall be labelled with the words and in the manner specified for that purpose in those Schedules.

(2) The words specified in the Schedules referred to in subregulation (1) of this regulation shall not be modified in meaning by the addition of any other words or marks and shall— (a) be printed in red letters on a contrasting background or in some other colour on a red background; and (b) be easily legible on a separate label or surrounded by a line within which there must be no other words.

7. Directions as to use.

(1) No person shall sell— (a) any liquid of a classified drug or restricted drug in bottles of more than three thousand millilitres capacity unless the bottle is labelled with the words “NOT TO BE TAKEN”; (b) any embrocation, liniment, lotion or antiseptic, or other liquid medicine for external application which contains a classified drug or restricted drug, unless the container is labelled with the name of the article and the words “FOR EXTERNAL USE ONLY”; (c) hydrocyanic acid, or cyanide unless the container is labelled with the words “WARNING, THIS CONTAINER HOLDS A POISONOUS SUBSTANCE AND SHOULD BE OPENED AND USED BY A PERSON HAVING EXPERT KNOWLEDGE OF THE PRECAUTIONS TO BE TAKEN IN ITS USE”.

(2) Any person who fails to comply with any provision of this regulation commits an offence.

8. Containers for classified drug or restricted drug.

(1) No person shall keep, sell or consign any classified drug or restricted drug unless— (a) it is contained in a container impervious to the classified drug or restricted drug and sufficiently strong to prevent leakage arising from the ordinary risks of handling and transport; and (b) in the case of a liquid contained in a bottle of a capacity of not more than three thousand millilitres, not being a medicine made up ready for internal treatment of human ailments, the outer surface of the bottle is fluted vertically with ribs or grooves recognisable by touch.

(2) Subregulation (1)(b) of this regulation shall not apply to the sale or the keeping of a classified drug or restricted drug for the purpose of education, research or analysis by a person or institution concerned with scientific education, research or chemical analysis.

9. Special provisions with respect to hospitals.

(1) In any hospital, infirmary, dispensary, clinic, nursing home or other similar institution— (a) at which human ailments are treated, all classified drugs or restricted drugs not in actual use shall be kept under the control of the person in charge of the institution or any fit and proper person whose duties include the responsibility for the care and issue of such drugs; (b) at which medicines are dispensed in a dispensing or pharmaceutical department in the charge of a person appointed for that purpose— (i) no medicine containing a classified drug or restricted drug shall, except in a case of emergency, be supplied from that department for use in the wards, operating theatres or other sections of the institution except upon a written order signed by a duly qualified medical or dental practitioner or nursing sister or other qualified person in charge of a ward, theatre or other section of the institution; (ii) the person supplying such medicine shall label the container with words describing its contents and, in the case of medicines containing a classified drug or restricted drug other than a classified drug specified in the Third Schedule to these Regulations or in the First and Second

Schedules to the Act, an indication that the classified drug or restricted drug is to be stored in a place reserved solely for the storage of classified drugs or restricted drugs in accordance with the provisions of the Second Schedule to the Act.

(2) The person in charge of a hospital, infirmary, dispensary, clinic, nursing home or other similar institution shall, not less than once in every year, arrange and be responsible for the inspection of the following— (a) all stores, cupboards and other places where classified drugs or restricted drugs are kept in the institution; (b) the methods by which classified drugs or restricted drugs are issued, dispensed and used in the institution; and (c) the books and any other records whatsoever kept in the institution for the purpose of recording the purchase, issue and use of classified drugs or restricted drugs.

(3) The person authorised to carry out the inspection under subregulation (2) of this regulation— (a) shall be a registered pharmacist or a duly qualified medical practitioner; (b) shall report in writing on his or her inspection and shall point out in his or her report any defects in the storage, methods of handling, or records of classified drugs or restricted drugs in the institution and shall make recommendations for the remedy of those defects; and (c) shall submit copies of his or her report— (i) to the person in charge of the institution, if that person has not himself or herself carried out the inspection; (ii) to the governing body of the institution.

(4) Any person who fails to comply with any provision of this regulation commits an offence.

10. Marking of packages or bottles.

(1) No person shall supply any classified drug or restricted drug unless the packages or bottles containing the drug are plainly marked with the nature and amount of the drug contained in the packages or bottles.

(2) No person shall supply any preparation, admixture, extract or

other article containing any classified or restricted drug unless the package or bottle is plainly marked— (a) in the case of powder, solution or ointment, with the total amount of the drug in the package or bottle and the percentage of the drug in the powder, solution or ointment; (b) in the case of tablets or other articles, with the amount of the drug in each article and the number of articles in the packages or bottle.

(3) This regulation shall not apply to any preparation dispensed by, or on the prescription or order of, a registered or licensed medical practitioner.

11. Specified provisions with respect to gifts by representatives.

A representative of a person engaged in the sale and supply of pharmaceutical goods is authorised to give free samples of those goods to persons who may lawfully possess classified drugs if the representative— (a) is in possession of a permit issued to him or her by the drug authority authorising him or her to do so; and (b) gives the following particulars, within twenty-four hours after the classified or restricted drug has been given— (i) the date on which the classified drug was given; (ii) the name and quantity of the classified drug or restricted drug given; and (iii) the name, address and signature of the person to whom the classified drug or restricted drug was given.

12. Special provisions with respect to midwives.

(1) A midwife, registered or enrolled under the provisions of the Nurses and Midwives Act, who is in private practice, is authorised to purchase, supply or dispense classified drugs or restricted drugs; provided that— (a) the midwife is in possession of an authority in writing from the Nurses and Midwives Council to practise as such under the Act; and (b) the maximum quantity of the classified drug or restricted drug which the midwife may possess shall not, at any time, exceed— (i) injection procaine penicillin fortified, 400,000 units per vial (10 vials), an antibiotic;

(ii) injection ergometrine, 0.5 mg. (12 ampoules) an alkaloid of ergot; (iii) chloral hydrate mixture containing 1 gramme per dose (40 grammes of chloral hydrate); (iv) sulphadimidine tablets, 0.5 gm. (200 tablets); (v) injection paraldehyde, 10 ml. (12 ampoules); (vi) injection morphine sulphate, 15 mg. per ml. (10 ampoules); (vii) injection hydrochloride, 100 gm. per 2 ml. (10 ampoules); (viii) injection , 2 ml. per ampoule (10 ampoules).

(2) Any midwife who fails to comply with any provision of this regulation and any person who sells by retail any classified drug or restricted drug to such midwife in contravention of section 13(3) of the Act commits an offence.

Manufacture and sale of narcotics, etc.

13. Possession of narcotics and psychotropic substances.

The drugs in— (a) the Fourth Schedule to these Regulations are narcotic drugs; (b) the Fifth Schedule to these Regulations are psychotropic substances.

14. No person to manufacture certain drugs without licence or authority.

A person shall not manufacture or carry on any process in the manufacture of any drug specified in the Fourth and Fifth Schedules to these Regulations unless— (a) he or she has a limited licence issued by the drug authority or is authorised by this Part of these Regulations or by any person authorised by the drug authority to do so; (b) he or she uses premises specifically licensed for the purpose by the drug authority; (c) he or she does it in accordance with the terms and conditions of the licence or authority.

15. Licence to supply narcotics, etc.

No person shall supply or procure or offer to supply any narcotic drug to or for any person (including himself or herself) and whether in Uganda or elsewhere, or advertise such drug for sale— (a) unless he or she is licensed by the drug authority, or authorised by these Regulations or by any authority granted by the drug authority to supply the drugs, or unless he or she is licensed by the drug authority to import or export the drugs, or unless he or she is licensed or otherwise authorised to manufacture the drugs, or (but so far only as regards procuring) unless he or she is licensed to procure the narcotic drugs; (b) otherwise than in accordance with the terms and conditions of the licence or authority.

16. Persons authorised to possess and supply narcotics and psychotropic substances without licence.

Any of the following persons is authorised, so far as is necessary for the practice of his or her profession or employment, to possess and supply such drugs— (a) any registered or licensed medical practitioner; (b) any registered or licensed dentist; (c) any drug registered veterinary surgeon; (d) any registered pharmacist; (e) any person employed in dispensing medicines at any public hospital or other public institution; (f) any person in charge of a laboratory for the purposes of research or instruction approved by the drug authority for that purpose; and (g) the Government chemist or analyst.

17. Delivery of drugs to messengers.

(1) No person shall deliver any narcotic drug or psychotropic drug to any person (not licensed or otherwise authorised to be in possession of the drug) who purports to be sent by or on behalf of the person so licensed or authorised unless— (a) that person produces an authority in writing signed by the person so licensed or authorised to receive the drug on his or her behalf; and (b) the person supplying the drug is satisfied that the authority is genuine.

(2) A person to whom a narcotic drug or psychotropic drug is lawfully delivered under subregulation (1) of this regulation shall be deemed to be a person authorised to be in possession of the narcotic or psychotropic drug sufficient to enable him or her to deliver it to the recipient.

18. Preservation of records.

Prescriptions, orders, records, registers or other documents required to be retained or kept under these Regulations shall be preserved for not less than two years from the date of the prescription, order, document or the last entry in the record or register, as the case may be.

Import and export of narcotic drugs and psychotropic drugs.

19. Export of drugs.

(1) Upon the production of an import licence duly issued by the competent authority in any country, the drug authority may issue an export licence in Form B set out in the Eighth Schedule to these Regulations in respect of any drug referred to in the import licence to any person who is named as the exporter in the licence, and is, under the Act, otherwise lawfully entitled to export the drug from Uganda.

(2) The export licence shall be in triplicate and two copies shall be issued to the exporter, who shall send— (a) one copy with the drug to which it refers, when that drug is exported; (b) one copy to the drug authority; and (c) one copy to the appropriate authority of the country of ultimate destination.

(3) Where the intended exportation is to a country which is not a party to the Geneva Convention (No. 1), it shall not be necessary to produce an import licence as required under subregulation (1) of this regulation.

(4) In all cases it shall be in the discretion of the drug authority to issue or refuse to issue an export licence.

(5) No drug shall be exported from Uganda unless the consignor is in possession of a valid export licence relating to the drug granted under this

regulation.

(6) At the time of exportation of any drug, the exporter shall produce to the commissioner of customs and excise the narcotic or psychotropic drug, the export licence relating to it, and such other evidence as the commissioner may require to satisfy himself or herself that the drug is being lawfully exported to the place and person named in the licence which refers to it.

(7) Any person who exports, causes to be exported or takes any step preparatory to exporting any drug from Uganda otherwise than in accordance with these Regulations commits an offence.

20. Import of drugs.

(1) An import licence may be granted by the drug authority in Form A of the Sixth and Seventh Schedules to these Regulations which shall permit the holder to import into Uganda any drug specified in the licence subject to such conditions as the drug authority may deem fit to impose.

(2) Every import licence shall be issued in duplicate one copy of which shall be forwarded by the intending importer to the person from whom the drug is to be obtained.

(3) No drug shall be imported into Uganda unless the person to whom the drug is consigned is in possession of a valid import licence issued in accordance with this regulation.

(4) Every drug imported into Uganda from a country which is a party to the Geneva Convention (No. 1) shall be accompanied by a valid export licence or a diversion certificate.

(5) Any person who imports, causes to be imported or takes any steps preparatory to importing any drug into Uganda otherwise than in accordance with these Regulations commits an offence.

21. Restriction of sales by licensed sellers.

No person shall be entitled, by virtue of being licensed, to sell, or offer for sale— (a) any restricted drug included in column one of Part A of the Third Schedule to these Regulations unless the article or substance sold

is one of the articles or substances specified against the description of the poison in column two of Part A of that Schedule, and the container of the substance is, in addition to any other direction of the Act or these Regulations with respect to labelling, labelled clearly with a notice of the special purpose for which the article or substance is intended, and a warning that it is only to be used for that purpose; (b) any restricted drug included in Part B of the Third Schedule to these Regulations, unless the purchaser of the restricted drug is engaged in the trade or business of agriculture or horticulture and requires the restricted drug for the purpose of that trade or business.

22. Metric system and imperial system.

(1) For the purposes of these Regulations, a restricted drug shall not be regarded as sold, issued or supplied otherwise than in accordance with a prescription or other order by reason only that the prescription or order specified a quantity of the restricted drug in terms of the imperial system and the quantity sold, issued or supplied is the equivalent of that amount in the metric system.

(2) In the case of a restricted drug which is defined as such within the meaning of the Weights and Measures (Equivalents for Dealing in Drugs) Regulations, the quantity of the restricted drug in the metric system which is the equivalent of a particular quantity in the imperial system shall, for the purposes of these Regulations, be deemed to be the appropriate equivalent quantity ascertained in accordance with these Regulations.

23. Offences and penalties.

Any person who commits an offence under any provision of these Regulations is liable to a fine not exceeding three thousand shillings or to a term of imprisonment not exceeding three months or to both.

_____

SCHEDULES

First Schedule. regs. 4(2)(b)(iii), 5(1)(a). Indication of character of article prescribed for the purposes of section 25 of the Act.

1. To be labelled with the words, Medicines made up ready for the “Caution. It is dangerous to internal treatment of human take this preparation except ailments and containing insulin under medical supervision” 2. To be labelled with the words, Medicines made up ready for the “Poison. For animal treatment treatment of animals only” 3. To be labelled with the words, Medicines (other than medicines “Caution. It is dangerous to containing insulin and medicines exceed the stated dose” mentioned in paragraph 9 of this Schedule) made up ready for the internal treatment of human ailments except in the case of a substance included in the First Schedule 4. To be labelled with the words, Preparations for the dyeing of hair “Caution. This preparation may containing phenylene diamines, cause serious inflammation of tolylene diamines or other the skin in certain persons and alkylated-benzene diamines, or should be used only in their salts accordance with expert advice” 5. To be labelled with the words Potassium hydroxide, sodium “Caution. This substance is hydroxide and articles containing caustic” either of those substances

6. To be labelled with the words, Dinitrocresols (DNOC); their “Caution. This substance is compounds with a metal or a poisonous. The inhalation of base except preparations for the its vapour, mist, spray or dust treatment of human ailments and may have harmful except winter washes containing consequences. It may also be not more than the equivalent of 5 dangerous to let it come into percent of dinitrocresols contact with the skin or Dinosam; its compounds with a clothing” metal or a base Dinoseb; its compounds with a metal or a base Drazoxolon; its salts Endosulfan Endothal; its salts Endrin Fluoroacetamide; fluoroacetanilide Organic compounds of mercury in aerosols Organo-tin compounds, compounds of fentin Phosphorous compounds, the following— Amiton Azinphos-ethyl Azinphos-methyl Chlorfenvinphos Demeton-O Demeton-S Dichlorvos Diethyl 4-methyl-7-coumarinyl phosphorothionate Diethyl p-nitrophenyl phosphate Dimefox Disulfoton Ethion Ethyl-p-nitrophenyl phenylphosphonothionate

Mazidox Mecarbam Mevinphos Mipafox Oxydemeton-methyl Parathion Phenkapton Phorate Phosphamidon Schradan Sulfotep TEPP (HETP) Tionazin Triphosphoric pentadim- ethylamide Vamidothion Sodium 4-(dimethylamino) benzenediazosulphonate 7. To be labelled with the words, Medicines made up ready for the “Caution. This preparation internal or external treatment of ahould be administered only human ailments and containing under medical supervision. dyfolos The vapour is dangerous” 8. To be labelled with the words, Monofluoroacetic acid; its salts “Caution. This substance is poisonous. Inhalation of the powder is dangerous. It is also dangerous to let the substance come into contact with the skin or clothing” 9. To be labelled with the words, Medicines made up ready for the “Caution. This may cause internal treatment of human drowsiness. If affected, do not ailments if the poison is one of the drive or operate machinery” following— substances, the following: their salts; their molecular compounds

Antazoline Bromodiphenhydramine Chlorpheniramine 3-Di-n-butylaminomethyl-4, 5, 6- trihydroxyphthalide Diphenylpyraline Meclozine Substances being tetra-N- substituted derivatives of or propylenediamine

_____

Second Schedule. reg. 5(1). Statement of particulars permitted in certain cases as to proportion of poison.

Name of poison Particulars Alkaloids— The proportion of any one alkaloid the Aconite, alkaloids of preparation would be calculated to contain on the assumption that all the alkaloids of aconite in the preparation were that alkaloid Alkaloids— The same as above, with the substitution Belladonna, alkaloids of for the reference to aconite of a reference to Calabar bean, alkaloids of belladonna, calabar bean or such other of , alkaloids of the said poisons as the case may require Colchicum, alkaloids of Ephedra, alkaloids of Ergot, alkaloids of Gelsemium, alkaloids of Jaborandi, alkaloids of Lobelia, alkaloids of Pomegranate, alkaloids of Quebracho, alkaloids of other than the alkaloids of red quebracho Sabadilla, alkaloids of Solanaceous alkaloids not otherwise included in the poisons list Stavesacre, alkaloids of Veratrum, alkaloids of Yohimba, alkaloids of Antimonial poisons The proportion of antimony trioxide

(Sb2O3) or antimony pentoxide (Sb2O5) the preparation would be calculated to contain on the assumption that the antimony (Sb) in the poison had been wholly converted into antimony trioxide or antimony pentoxide as the case may be

Name of poison Particulars

Arsenical poisons The proportion of arsenic trioxide (As2O3) or arsenic pentoxide (As2O5) that the preparation would be calculated to contain on the assumption that the arsenic (As) in the poison had been wholly converted into arsenic trioxide or arsenic pentoxide as the case may be Barium, salts of The proportion of one particular barium salt which the preparation would be calculated to contain on the assumption that the barium (Ba) in the poison had been wholly converted into that salt Digitalis, glycosides of; other The number of units of activity as defined active principles of digitalis in the British Pharmacopoeia contained in a specified quantity of the preparation Hydrocyanic acid; cyanides other The proportion of hydrocyanic acid (HCN) than ferrocyanides and that the preparation would be calculated to ferricyanides contain on the assumption that the cyanides in the poison had been wholly converted into hydrocyanic acid Insulin The number of units of activity as defined in the British Pharmacopoeia contained in a specified quantity of the preparation

Lead, compounds of, with acids The proportion of lead oxide (PbO) that the from fixed oils preparation would be calculated to contain on the assumption that the lead in the poison had been wholly converted into lead oxide Mercury, organic compounds of The proportion of organically-combined mercury (Hg) contained in the preparation Nux Vomica The proportion of contained in the preparation Opium The proportion of morphine contained in the preparation Phenols The proportion of phenols (added together) contained in the preparation

Name of poison Particulars Compounds of a phenol with a The proportion of phenols (added together) metal that the preparation would be calculated to contain on the assumption that the compounds of phenols with a metal had been wholly converted into the corresponding phenols Pituitary gland, the active Either— principles of (a) the number of units of activity as defined in the British Pharmacopoeia contained in a specified quantity of the preparation; (b) the proportion of pituitary gland, or of anterior or of posterior lobe of the gland, as the case may be, contained in the preparation; or (c) the amount of pituitary gland, or of anterior or of posterior lobe of the gland, as the case may be, from which a specified quantity of the preparation was obtained, together with an indication whether the amount related to fresh or to dried gland substance Potassium hydroxide The proportion of potassium monoxide

(K2O) which the preparation would be calculated to contain on the assumption that the potassium hydroxide in the preparation had been wholly converted into potassium monoxide Strophanthus, glycosides of The amount of standard tincture of strophanthus as defined in the British Pharmacopoeia 1948 which possesses the same activity as a specified quantity of the preparation when assayed by the method described in that Pharmacopoeia

Name of poison Particulars Suprarenal gland medulla, the Either— active principles of; their salts (a) the proportion of suprarenal gland or of the medulla of the gland, as the case may be, contained in the preparation; or (b) the amount of suprarenal gland or of the medulla of the gland, as the case may be, from which a specified quantity of the preparation was obtained, together with an indication whether the amount relates to fresh or to dried gland substance Thyroid gland, the active Either— principles of; their salts (a) the proportion of thyroid gland contained in the preparation; or (b) the amount of thyroid gland from which a specified quantity of the preparation was obtained, together with an indication whether the amount relates to fresh or to dried gland

_____

Third Schedule. regs. 9, 21. Limitations on forms of sale and buyers of restricted drugs.

Part A. Form to which the substances specified are restricted when sold by licensed sellers of restricted drugs of class C.

Restricted drug Forms to which sale is restricted Alpha-chloralose Preparations intended for indoor use in the destruction of rats or mice and containing not more than 4 percent, weight in weight, of alpha-chloralose Arsenical substances— Arsenic sulphides Sheep dips, sheep washes Arsenious oxide Sheep dips, sheep washes Calcium arsenites Agricultural and horticultural insecticides or fungicides Copper acetoarsenite Agricultural and horticultural insecticides or fungicides Copper arsenate Agricultural and horticultural insecticides or fungicides Copper arsenites Agricultural and horticultural insecticides or fungicides Lead arsenates Agricultural and horticultural insecticides or fungicides Sodium arsenates Sheep dips, sheep washes Sodium thioarsenates Sheep dips, sheep washes Barium carbonate Preparations for the destruction of rats or mice Dinitrocresols (DNOC); their Preparations for use in agriculture or compounds with a metal or a horticulture base Dinosam; its compounds with a Preparations for use in agriculture or metal or a base horticulture Drazoxolon; its salts Preparations for use in agriculture or horticulture Endosolfan Preparations for use in agriculture or horticulture

Restricted drug Forms to which sale is restricted Endothal; its salts Preparations for use in agriculture or horticulture Endrin Preparations for use in agriculture or horticulture Mercurial substances— Agricultural and horticultural fungicides, seed and bulb dressings Mercuric chloride Agricultural and horticultural fungicides, seed and bulb dressings, insectides Mercuric iodide Agricultural and horticultural fungicides, seed and bulb dressings Organic compounds of Agricultural and horticultural fungicides, mercury seed and bulb dressings, solutions containing not more than 5 percent, weight in volume, of phenyl mercuric acetate for use in swimming baths Metallic oxalates other than Photographic solutions or materials potassim quadraxalate Nitrobenzene Agricultural and horticultural insecticides; substances for the treatment of bee disease; ointments for the treatment of animals Organo-tin compounds, the Preparations for use in agriculture or compounds of fentin horticulture

Restricted drug Forms to which sale is restricted Phosphorus compounds, the following— Amiton Azinphos-ethyl Azinphos-methyl Chlorfenvinphos Demeton-O Demeton-S Dichlorvos Diethyl 4-methyl-7- coumarinyl phosphorothionate Diethyl p-nitrophenyl phosphate Dimefox Disulfoton Ethion Ethyl p-nitrophenyl phenyl- Preparations for use in agriculture or phosphonothionate horticulture Mazidox Mecarbam Mevinphos Mipafox Oxydemeton-methyl Parathion Phenkapton Phorate Phosphamidon Schradan Sulfotep TEPP (HETP) Triphosphoric pentadimethylamide Vamidothion Sodium 4-(dimethylamino) benzenediazosulphonate Phosphorus compounds, Zinc Preparations for the destruction of rats or phosphide mice

Part B. Restricted drugs which may be sold by listed sellers of class C only to persons engaged in the trade or business of agriculture or horticulture and for the purpose of that trade or business.

Arsenical poisons other than lead arsenates and copper acetoarsenite Dinitrocresols (DNOC); their compounds with a metal or a base; except winter washes containing not more than the equivalent of 5 percent of dinitrocresols Dinosam; its compounds with a metal or a base Dinoseb; its compounds with a metal or a base Drazoxolon; its salts Mercuric chlorides; mercuric iodides; organic compounds of mercury; except solutions containing not more than 5 percent weight in volume, of phenyl mercuric acetate for use in swimming baths Niclofolan Organo-tin compounds, compounds of fentin Phosphorus compounds, the following— Amiton Azinphos-ethyl Azinphos-methyl Chlorfenvinphos Demeton-O Demeton-S Dichlorvos Diethyl 4-methyl-7-coumarinyl phosphorothionate Diethyl p-nitrophenyl phosphate Dimefox Disulfoton Ethion Ethyl p-nitrophenylphosphonothionate Mazidox Mecarbam Mevinphos Mipafox, except in the form of a cap on a stick or wire Oxydemeton-methyl Parathion Phenkapton Phorate Phosphamidon Schradan

Sulfotep Thionazin Triphosphoric penetadimethylamide Vamidothion Sodium 4(dimethylamino) benezenediazosulphonate

_____

Fourth Schedule. regs. 13, 14. Substances dealings in which are subject to control under international conventions.

Part I. Substances dealings in which are subject to control, except in the case of any specified in Part II below, as regards importation and exportation.

1. The following substances—

Acetyldihydrocodeine Ethylmorphine (3-ethylmorphine) Allylprodine Etonitazene Alphacetylmethadol Etoxeridine Alphameprodine Fentanyl Alphamethadol Furethidine Alphaprodine Hydrocodone (dihydrocodeinone) Anileridine Hydromorphinol Benzethidine Hydromorphone Benzylmorphine (3-benzylmorphine) Hydroxypethidine Betacetylmethadol Isomethadone Betameprodine Ketobemidone Betaprodine Clonitazene Levomoramide Codeine Levophenacylmorphan Desomorphine Dextromoramide Metazocine Diamorphine Methadyl acetate Diampromide (N-12-(N-methyl- Methyldihydromorphine (6-methyl- phenethylamino) propyl dihydromorphine) Propionanilide Morpheridine Diethylthiambutene Morphine Dihydrocodeine Morphine methobromide morphin-N- Dihydromorphine oxide and other pentavent Dimenoxadole nitrogen morphine derivatives Dimephetanol Myrophine Dimethylthiambutene Nicocodine Dioxaphetyl butyrate Nicomorphine (3, 6-dinicotinoyl- Diphenoxylate morphine) Dipipanone Noracymethadol Ecgonine Norcodeine Ethylmethylthiambutene Norlevorphanol Normethadone

Normorphine Racemethorphan Norpipanone Racemoramide Oxycodone Oxymorphone Thebacon Pethidine Thebaine Phenadozone Trimeperidine Phenampromide 4-Cyano-2-dimethylamino-4, Phenazocine 4-diphenylbutane Phenomorphan 4-Cyano-1-methyl-4-phenyl- Phenoperidine Pholcodine 1-Methyl-4-phenylpiperidine- Piminodine 4-carboxylic acid Proheptazine 2-Methyl-3-morpholino-1, Properidine (1-methyl-4-phenyl- 1-diphenylpropanecarboxylic piperidine-4-carboxylic acid iso- acid Propyl ester) 4-Phenylpiperidine-4-carboxylic acid ethyl ester

2. Any ester (other than one expressly mentioned in paragraph 1 above) or ether (other than one so mentioned) of a substance for the time being specified in that paragraph.

3. Any salt of a substance for the time being specified in paragraph 1 or 2 above.

4. Any derivative of ecgonine which is convertible to ecgonine or to .

5. Concentrate of poppy-straw (that is to say, the material arising when poppy-straw has entered into a process for the concentration of its alkaloids).

6. Medicinal opium.

7. Any extract or tincture of cannabis.

8. Any preparation, admixture, extract or other substance containing any proportion of a substance for the time being specified in paragraph 1 above or in any of paragraphs 2 to 7 above.

Part II. Preparations and other substances falling within Part I whose importation and exportation is excepted from control.

9. (1) Preparation of not more than one of the substances to which this paragraph applies, when— (a) compounded with one or more other ingredients in such a way that the preparation has no, or a negligible, risk of abuse, and that the substance cannot be recovered by readily applicable means or in a yield which would constitute a risk to health; and (b) containing not more than 100 milligrammes of the substance per dosage unit and with a concentration of not more than 2.5 percent in undivided preparations.

(2) The substances to which this paragraph applies are acetyldihydrocodeine, codeine, dextropropoxyphene, dihydrocodeine, ethylmorphine (3-ethylmorphine), norcodeine, pholcodine and their respective salts.

10. A preparation of cocaine containing not more than 0.1 percent of cocaine calculated as cocaine base, being a preparation compounded with one or more other ingredients in such a way that the preparation has no, or a negligible, risk of abuse and that the cocaine cannot be recovered by readily applicable means or in a yield which would constitute a risk to health.

11. A preparation of medicinal opium or of morphine containing (in either case) not more than 0.2 percent of morphine calculated as anhydrous morphine base, being a preparation compounded with one or more other ingredients in such a way that the preparation has no, or a negligible, risk of abuse and that the opium or, as the case may be, the morphine, cannot be recovered by readily applicable means or in a yield which would constitute a risk to health.

12. Solid dose preparations of diphenoxylate containing, per dosage unit, not more than 2.5 milligrammes of diphenoxylate calculated as base and not less than 2.5 microgrammes of sulphate.

13. Pulvis ipecacuanhae et opii compositus— (a) 10 percent, opium, in powder;

(b) 10 percent, ipecacuanha root, in powder, well mixed with 80 percent of any other powdered ingredient containing neither a drug to which Part I or II of this Schedule applies nor a substance for the time being specified in paragraph 1 of this Schedule or in any of paragraphs 2 to 8 of this Schedule.

14. Mixtures containing not more than one of the preparations specified in paragraphs 9 to 13 above, being mixtures of which none of the other ingredients is either a drug to which Part I or II of this Schedule applies or a substance for the time being specified in paragraph 1 of this Schedule or in any of paragraphs 2 to 8 of this Schedule.

_____

Fifth Schedule. regs. 13, 14. List of psychotropic substances included in the Schedules annexed to the Convention of 21st February, 1971.

Group I.

International Other Chemical names nonproprietary nonproprietary or names1 trivial names1 1. DET N, N-diethyltryptamine 2. DMHP 3-(1, 2-dimethylheptyl)-1-hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl- 6H-dibenzo [b, d] pyran 3. DMT N, N-dimethyltryptamine 4. (+)-Lysergide LSD, LSD-25 (+)-N, N-diethyllsergamide (d-lysergic acid diethylamide) 5. mescaline 3, 4, 5-trimethoxyphenethylamine 6. parahexyl 3-hexyl-1-hydroxy-7, 8, 9, 10- tetrahydro-6, 6, 9-trimethyl-6H- dibenzo [b, d] pyran 7. psilocine, psilotsin 3-(2-dimethylaminoethyl)-4- hydroxyindole 8. Psilocybine 3-(2-dimethylaminoethyl) indol-4-yl dihydrogen phosphate 9. STP, DOM 2-amino-1-(2, 5-dimethoxy-4-methyl) phenylpropane 10. tetrahydrocannabin 1-hydroxy-3-pentyl-6a, 7, 10a- ols, all isomers tetrahydro-6, 6, 9-trimethyl-6H- dibenzo [b, d] pyran

1With the exception of (+)-Lysergide, other nonproprietary or trivial names are given only where no other international nonproprietary name has been yet proposed.

Group II.

International Other Chemical names nonproprietary names2 nonproprietary or trivial names2 1. (±)-2-amino-1-phenylpropane 2. Dexamphetamine (+)-2-amino-1-phenylpropane 3. (+)-2-methylamino-1- phenylpropane 4. 2-phenyl-2-(2-piperidyl) acetic acid, methyl ester 5. 1-(1-phenylcyclohexyl) piperidine 6. 3-methyl-2-phenylmorpholine

Group III.

International Other Chemical names nonproprietary nonproprietary or names2 trivial names2 1. Armobarbital 5-ethyl-5-(3-methylbutyl) barbituric acid 2. Cyclobarbital 5-(1-cyclohexen-1-yl)-5- ethylbarbituric acid 3. Glutethimide 2-ethyl-2-phenylglutarimide 4. 5-ethyl-5-(1-methylbutyl) barbituric acid 5. Secobarbital 5-allyl-5-(1-methylbutyl) barbituric acid

2With the exception of (+)-Lysergide, other nonproprietary or trivial names are given only where no other international nonproprietary name has been yet proposed.

Group IV.

International Other Chemical names nonproprietary names3 nonproprietary or trivial names3 1. 2-(diethylamino) propiophenone 2. Barbital 5,5-diethylbarbituric acid 3 ethchlorvynol ethyl-2-chlorovinylethinyl- carbinol 4. Ethinamate 1-ethynylcyclohexanol-carbamate 5. Meprobamate 2-methyl-2-propyl-1, 3- propanediol dicarbamate 6. Methaqualone 2-methyl-3-o-tolyl-4 (3H)- quinazolinone 7. Methylphenobarbital 5-ethyl-1-methyl-5-phenyl- barbituric acid 8. Methypryion 3, 3-diethyl-5-methyl-2, 4- piperidine-dione 9. Phenobarbital 5-ethyl-5-phenylbarbituric acid 10. 1, 1-diphenyl-1-(2-piperidyl) methanol 11. SPA (-)-1-dimethylamine-1, 2-dip- henylethane

_____

3With the exception of (+)-Lysergide, other nonproprietary or trivial names are given only where no other international nonproprietary name has been yet proposed.

Sixth Schedule. reg. 20. Import authorisation and certificate of official approval of import.

Republic of Uganda M.F. 129. Serial No. ______File No. ______Indent No. ______

Ministry of Health.

Form A. Import Authorisation and Certificate of Official Approval of Import. The National Drug Policy and Authority Regulations.

I, ______, being the person charged with the administration of the law relating to the narcotic drugs to which the International Opium Conventions apply, certify that I have authorised ______(here insert name and full postal address of importer) (hereafter called the “importer”) to import the drugs specified in the Schedule to this authorisation, which I am satisfied are required— (a) for legitimate purposes1 (in the case of raw opium or the coca leaf); or (b) solely for medicinal or scientific purposes1 (in the case of Indian hemp or drugs to which Chapter III of the International Opium Convention, 1925, applies). from ______(here insert name and full postal address of exporter.)

1Strike out words not applicable.

This authorisation is issued subject to the following conditions—

1. The drugs shall be imported before ______(date).

2. This authorisation is not a licence to be in possession of or to supply the drug imported.

3. This authorisation does not relieve the importer from compliance with any customs regulations in force for the time being relating to the importation of goods into or transhipment of goods in Uganda or any post office regulations for the time being in force in Uganda.

4. This authorisation is valid only for the importer and may be revoked at any time and in that event shall be immediately surrendered. It shall be produced for inspection when required by any duly authorised person.

5. This authorisation unless sooner revoked shall be surrendered to the customs officer at the time of importation, or, if the importation is not effected before the date specified in condition No. 1, shall immediately after that date be surrendered to the chief medical officer.

6. The copy of the export authorisation, if any, which accompanies the consignment shall be forwarded to the drug authority immediately after the importation of the consignment has been effected.

7. The consignment shall be imported by registered parcel post addressed to ______.

______(Place, date and stamp) National Drug Authority, (Issuing Authority for Uganda)

Schedule to the Authorisation.

Specifying the drugs and quantities of the drugs to be imported. ______

One copy of this authorisation is to be retained by the importer and is not to leave his or her possession until it is surrendered to the drug authority or to the customs officer, who will

complete the certificate on the back and return it to the drug authority.

Endorsement by Customs Officer at the Time of Importation.

I certify that the person named overleaf has today imported the consignment thereon specified1 ex2______under Customs Entry No. ______dated ______by registered parcel post or insured box post3 (Parcel No. ______dated ______).

______Signature of Customs Officer Rank ______Port ______Date ______Port Stamp

Amount Description of items

This authorisation, when completed, must be returned by the customs officer to the chief medical officer, Entebbe, Uganda.

_____

1 If the whole of the drugs for which this authorisation has been granted is not imported, the customs officer should suitably amend the certificate above, and insert below the actual amount or items imported. 2 Insert name of conveyance. 3 Strike out all words not applicable.

Seventh Schedule. reg. 20. Duplicate of import licence.

Telegrams: “Medmin.” Ministry of Health Telephone: 2201 P.O. Box 8 Entebbe, Uganda

Republic of Uganda

Duplicate of Import Licence. The National Drug Policy and Authority Regulations.

Dear Sir/Madam,

Re: Duplicate of Import Licence Serial No. ______, Form A

I forward with this letter the duplicate of Import Authorisation and Certificate of Official Approval of Import No. ______, Form A, issued to ______for favour of comparison in due course with relevant export authorisation and return to this office.

I have the honour to be, Your obedient servant,

______For the National Drug Authority

The Commissioner of Customs P.O. Box 444, Kampala

_____

Eighth Schedule. reg. 19. Export authorisation. M.F. 128.

Serial No.______File No. ______Applicant’s Ref. No. ______

Republic of Uganda

Form B. Export Authorisation. The National Drug Policy and Authority Regulations.

In pursuance of the National Drug Policy and Authority Regulations, the National Drug Authority authorises ______(hereafter called “the exporter”) to export from1— (a) the port of ______by s.s. ______; (b) Uganda by parcel post ______; (c) Uganda in manner otherwise described, to ______in virtue of Import Certificate No. ______issued by ______dated ______the following drugs—

1Strike out words not applicable.

Conditions.

This authorisation is issued subject to the following conditions—

1. This authorisation is not a licence to obtain or be in possession of the drugs named in it.

2. This authorisation is available only for drugs of the exact quantity, kind and form specified above.

3. This authorisation does not relieve the exporter from compliance with any customs regulations in force for the time being relating to the exportation of goods from Uganda nor from any provision of the Uganda Posts and Telecommunications Corporation Act, or of any post office regulations for the time being in force, nor from any rules or regulations respecting the transmission of articles by post which may for the time being be in force, whether within Uganda or elsewhere.

4. If the drugs are authorised to be exported by ship the duplicate copy, which is attached, shall accompany the consignment to the place of destination, and for this purpose the exporter shall cause it to be delivered to the master of the vessel by which the consignment is dispatched. (See note (3))

5. If the drugs are authorised to be exported by post the attached duplicate copy shall be placed inside the outer wrapper of the parcel containing the drugs. If the drugs are contained in more than one parcel, the duplicate copy shall be placed inside the outer wrapper of one of them; the parcels shall be consecutively numbered on the outer wrapper, and on each parcel there shall be legibly stated the number of the parcel in which the duplicate copy is to be found. (See note (4))

6. The exporter, if so required by the commissioner of customs shall produce to him or her, within such time as he or she may allow, proof to his or her satisfaction that the drugs were duly delivered at the destination named in this authorisation, and in the event of noncompliance with this condition the authorisation shall be deemed void and of no effect.

7. The exporter shall furnish to the drug authority such returns of the goods, exported by him or her in pursuance of this authorisation as may

from time to time be required.

8. This authorisation is valid only for the exporter named above and may be revoked at any time by the drug authority. It shall be produced for inspection when required by any duly authorised person.

9. This authorisation, unless sooner revoked, shall continue in force for three calendar months from the date shown below. It must be produced, at the time of export, to an officer of2— (a) the customs department; (b) the post office, who will retain it. If not used it shall be surrendered to the drug authority within seven days of the date of its expiry.

Date ______, 20 ____.

______Secretary, National Drug Authority

Notes— 1. Strike out words not applicable. 2. If any alteration is desired in this authorisation it must be returned with a request for amendment and a statement of the reasons for the amendment. No authorised alteration is permissible. 3. In the case of drugs exported by ship, this document is required in pursuance of the International Opium Convention, 1925, article 15, to be produced to the competent authorities of any country through which the consignment passes, whether it is transhipped or not. Failure to comply with the condition may lead to delay or confiscation of the consignment. (4) In the case of drugs exported by post, failure to comply with this condition may lead to delay or confiscation of the parcels in the country of destination.

_____

2Strike out words not applicable.

History: S.I. 41/1974.

Cross References

British Pharmaceutical Codex. British Pharmacopoeia. British Veterinary Code. Geneva Convention (No. 1). International Opium Convention, 1912 and 1925. International Pharmacopoeia. Nurses and Midwives Act, Cap. 274. Pharmacy and Drugs Act, Cap. 280. Uganda Posts and Telecommunications Corporation Act, Cap. 107. United States Pharmacopoeia. Weights and Measures (Equivalents for Dealing in Drugs) Regulations, S.I. 103-6.

_____